Abstract:Abstract Objectives Red raspberry (RR) polyphenols, including ellagic acid and their gut-derived metabolites, the urolithins, reduce inflammation and improve insulin sensitivity. However, it is unknown whether the gut microbiota is responsible for these health benefits and why certain individuals do not transform ellagic acid into urolithins. Here, we determined the causative role for the microbiome in mediating the health benefits from RR polyphenols using germ-free and conventionalized mouse models of diet-induced obesity. We also tested whether Gordonibacter urolithinfaciens (G. uro), a gut microbe previously shown to metabolize ellagic acid into urolithins, could enhance metabolic benefits when administered as a synbiotic with RR polyphenols. Methods RR polyphenols were extracted using a macroporous ion-exchange resin column to remove sugars and fibers. C3H/HeN mice with (CVZ) or without a microbiota (GF) were fed either a low fat (LF), high fat (HF), or HF diet with RR polyphenols (HF + RR) for 12 weeks. For synbiotic studies, GF C57BL/6 mice were given a G. uro deficient-microbiome and then fed either a HF or HF + RR diet plus 20% fructose water with or without G. uro for 7 weeks. Results Feeding a HF diet increased body weight and fat mass for both GF and CVZ mice compared to feeding a LF diet (P < 0.05). Feeding a HF diet with RR polyphenols significantly decreased visceral adipose tissue and liver triglycerides (P < 0.05) compared to a HF control diet in CVZ but not GF mice. G. uro administration to mice receiving a HF diet and fructose water significantly reduced body weight, body fat percentage, fasting blood glucose, and subcutaneous adipose tissue mass as well as increased ileal tight junction protein gene expression (P < 0.05) compared to controls. Notably, mice supplemented with both G. uro and RR polyphenols experienced no metabolic improvements compared to controls (P < 0.05). Conclusions Our results demonstrate that the microbiome is required for mediating RR polyphenol metabolic benefits. Supplementation of G. uro improved metabolic health; however, those beneficial effects were abrogated in the presence of RR polyphenols. Together, these results highlight the importance of considering specific diet-microbiota interactions when developing foods for preventing and treating obesity-related diseases. Funding Sources USDA NIFA.

Urolithin A production drives the pomegranate effects on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals

Prospective Randomized, Double-Blind, Placebo-Controlled Study of a Standardized Oral Pomegranate Extract on the Gut Microbiome and Short-Chain Fatty Acids

Pomegranate Fruit Pulp Polyphenols Reduce Diet-Induced Obesity with Modulation of Gut Microbiota in Mice.

Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota

Gut Bacteria Involved in Ellagic Acid Metabolism To Yield Human Urolithin Metabotypes Revealed

Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice

Recent Advances and Perspectives on the Health Benefits of Urolithin B, A Bioactive Natural Product Derived From Ellagitannins

Development of a liquid chromatography-tandem mass spectrometry (LC–MS/MS) method for characterizing pomegranate extract pharmacokinetics in humans

In vitro conversion of ellagic acid to urolithin A by different gut microbiota of urolithin metabotype A

Urolithin A and Ellagic Acid Inhibit Prostate Cancer Through Different Molecular Mechanisms: Implications of Gut Microbiome Metabolism for Cancer Prevention

Beneficial Effects of Pomegranate Peel Extract and Probiotics on Pre-adipocyte Differentiation

Pomegranate Supplementation Alleviates Dyslipidemia and the Onset of Non-Alcoholic Fatty Liver Disease in Wistar Rats by Shifting Microbiota and Producing Urolithin-like Microbial Metabolites

In vivo administration of gut bacterial consortia replicates urolithin metabotypes A and B in a non-urolithin-producing rat model

Gut microbiota composition in relation to the metabolic response to 12-week combined polyphenol supplementation in overweight men and women

The Modulatory Bioeffects of Pomegranate (Punica granatum L.) Polyphenols on Metabolic Disorders: Understanding Their Preventive Role against Metabolic Syndrome

Metabolic profiling, in vitro bioaccessibility and in vivo bioavailability of a commercial bioactive Epilobium angustifolium L. extract

Urolithins and intestinal health

The Gut Microbiota Regulates the Metabolic Benefits Mediated by Red Raspberry Polyphenols

Pomegranate peel polyphenols reduce chronic low-grade inflammatory responses by modulating gut microbiota and decreasing colonic tissue damage in rats fed a high-fat diet

Improved Cardiovascular Effects of a Novel Pomegranate Byproduct Extract Obtained through Hydrodynamic Cavitation

Pomegranate Juice Supplemented with Inulin Modulates Gut Microbiota and Promotes the Production of Microbiota-Associated Metabolites in Overweight/Obese Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial